Cerca | SPORTIVO Network

NikitaG ha aggiunto una foto Altre informazioni
2026-02-12 05:17:37

Hemophilia Gene Therapy Market to Hit USD 3.06 Billion by 2032
“According to a new report published by Introspective Market Research, Hemophilia Gene Therapy Market by Therapy Type, Indication, and End User, The Global Hemophilia Gene Therapy Market Size Was Valued at USD 0.5 Billion in 2023 and is Projected to Reach USD 3.06 Billion by 2032, Growing at a CAGR of 22.3% from 2024–2032.” The Hemophilia Gene Therapy Market is witnessing...

0 Commenti 0 condivisioni 933 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
priyanka ha aggiunto una foto Altre informazioni
2025-10-31 05:50:06

Hemophilia Market Trends, Analysis & Future Outlook (2024-2032)
Introspective Market Research recently introduced the Hemophilia Market Market study with 431+ pages of in-depth analysis. The report highlights the Hemophilia Market industry scope, market outlook, and status (2025–2032). The Hemophilia Market Market is segmented by key regions, accelerating market growth and adoption. At present, the Hemophilia...

0 Commenti 0 condivisioni 3K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Kumud ha aggiunto una foto Health
2026-04-06 12:35:59

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 Commenti 0 condivisioni 643 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Kumud ha aggiunto una foto Health
2026-04-06 12:37:24

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 Commenti 0 condivisioni 592 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!